noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Illinois Historic Preservation Agency

Heidecke Lake reopening to anglers in time for Illinois Free Fishing[...]
Sionna Therapeutics Inc.

Statement of Changes in Beneficial Ownership (Form 4)
University of Delaware

For the Record, June 18, 2026

Healthcare

Zentalis Pharmaceuticals Inc.

06/18/2026 | Press release | Distributed by Public on 06/18/2026 14:03

Proxy Results (Form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 16, 2026, Zentalis Pharmaceuticals, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting, a total of 49,453,766 shares of common stock were present online or represented by proxy at the meeting, representing approximately 69.47% of the Company's outstanding common stock as of the April 20, 2026 record date. The following are the voting results for the proposals considered and voted upon at the Annual Meeting, all of which were described in the Company's definitive proxy statement filed with the Securities and Exchange Commission on April 30, 2026, as supplemented on May 27, 2026.

Zentalis Pharmaceuticals Inc. published this content on June 18, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 18, 2026 at 20:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]